tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

AREAlexandria Real Estate Equities

Real estate · REIT · NYSE
Compare with peers → Embed
Planned sales, announced before they happen

0 trading plans running, 6 Form 144 notices for $1.9M

10-Q, 10-K and Form 144
Plans running now
0
none adopted and not yet ended or expired
Plans adoptedList ↓
5
reported since Apr 24, 2023
Form 144 noticesList ↓
6
$1.9M the sellers expected to sell

What ARE's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans

Plans adopted or ended

XBRL, 10-Q and 10-K
InsiderWhatDateSharesRuns toReported in
Hart Cole
Co-President & Co-Regional Market Director – Seattle
Ended 10b5-1 plan Jun 25, 2026 up to 20,000 Jan 29, 2027 10-Q Aug 3, 2026
Hallie E. Kuhn
Executive Vice President – Capital Markets and Co-Lead – Life Science
Ended 10b5-1 plan Jun 18, 2026 up to 2,574 Oct 16, 2026 10-Q Aug 3, 2026
What the company wrote
On June 18, 2026 , Hallie E. Kuhn , our Executive Vice President – Capital Markets and Co-Lead – Life Science , terminated a Rule 10b5-1 trading arrangement that she had previously adopted in December 2025 for the sale from time to time of up to 2,574 shares of common stock. The trading arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled to expire on October 16, 2026 . On June 25, 2026 , Hart Cole , our Co-President & Co-Regional Market Director – Seattle , terminated a Rule 10b5-1 trading arrangement that he had previously adopted in December 2025 for the sale from time to time of up to 20,000 shares of common stock. The trading arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled to expire on January 29, 2027 .
Marc E. Binda
Chief Financial Officer and Treasurer
Ended 10b5-1 plan Jun 17, 2026 up to 23,368 Dec 1, 2026 10-Q Aug 3, 2026
What the company wrote
On June 17, 2026 , Marc E. Binda , our Chief Financial Officer and Treasurer , terminated a Rule 10b5-1 trading arrangement that he had previously adopted in December 2025 for the sale from time to time of up to 23,368 shares of common stock. The trading arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled to expire on December 1, 2026 .
Hallie E. Kuhn
Executive Vice President – Capital Markets and Co-Lead – Life Science,
Adopted 10b5-1 plan Dec 15, 2025 up to 2,574 Oct 16, 2026 10-K Jan 26, 2026
What the company wrote
On December 15, 2025 , Hallie E. Kuhn , our Executive Vice President – Capital Markets and Co-Lead – Life Science, entered into a Rule 10b5-1 trading arrangement providing for the sale, from time to time, of up to 2,574 shares of common stock through October 16, 2026 .
Marc E. Binda
Chief Financial Officer and Treasurer
Adopted 10b5-1 plan Dec 15, 2025 up to 23,368 Dec 1, 2026 10-K Jan 26, 2026
What the company wrote
On December 15, 2025 , Marc E. Binda , our Chief Financial Officer and Treasurer , entered into a Rule 10b5-1 trading arrangement providing for the sale, from time to time, of up to 23,368 shares of common stock through December 1, 2026 .
Hart Cole
Co-President and Co-Regional Market Director – Seattle
Adopted 10b5-1 plan Dec 10, 2025 up to 20,000 Jan 29, 2027 10-K Jan 26, 2026
What the company wrote
On December 10, 2025 , Hart Cole , our Co-President and Co-Regional Market Director – Seattle , entered into a Rule 10b5-1 trading arrangement providing for the sale, from time to time, of up to 20,000 shares of common stock through January 29, 2027 .
Daniel J. Ryan
Co-President and Regional Market Director – San Diego
Adopted 10b5-1 plan Dec 16, 2024 up to 30,000 Aug 14, 2025 10-K Jan 27, 2025
What the company wrote
On December 16, 2024 , Daniel J. Ryan , our Co-President and Regional Market Director – San Diego , entered into a Rule 10b5-1 trading arrangement providing for the sale, from time to time, of up to 30,000 shares of common stock. The arrangement will be effective through August 14, 2025 . Mr. Ryan’s trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our insider trading policy.
Marc E. Binda
Chief Financial Officer and Treasurer
Adopted 10b5-1 plan Dec 12, 2024 up to 15,945 Dec 12, 2025 10-K Jan 27, 2025
What the company wrote
On December 12, 2024 , Marc E. Binda , our Chief Financial Officer and Treasurer , entered into a Rule 10b5-1 trading arrangement providing for the sale, from time to time, of up to 15,945 shares of common stock through December 12, 2025 . Mr. Binda’s trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our insider trading policy.

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 24, 2023.

Form 144

Notices of planned sales

Form 144 XML, SEC
FiledSellerSharesValueShares came from10b5-1 planForm 4 sales after
Sep 11, 2026 Fukuzaki-Carlson Kristina
Officer
16,810 $849K Restricted Stock Vesting none given 16,810 shares from Sep 11, 2026
Aug 31, 2026 Gavinet Andres
Officer
10,000 $509K Restricted Stock Vesting none given 10,000 shares from Aug 31, 2026
Jun 9, 2026 Binda Marc E
Officer
2,000 $108K Restricted Stock Vesting adopted Dec 15, 2025 2,000 shares from Jun 9, 2026
Apr 17, 2026 Kuhn Hallie E.
Officer
536 $26K Restricted Stock Vesting adopted Dec 15, 2025 none found
Feb 27, 2026 Gossett Bret E.
Officer, Director
4,702 $252K Restricted Stock Vesting none given none found
Dec 16, 2025 Alsbrook Madeleine Thorp
Officer
3,486 $161K Restricted Stock Vesting none given none found

From the Form 144 XML filed with the SEC, since Dec 16, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Next Owners →